MicroRNA-210 targets antiapoptotic Bcl-2 expression and mediates hypoxia-induced apoptosis of neuroblastoma cells

Archives of Toxicology

Volumn 87, Issue 3, 2013, Pages 459-468

  Chio, Chung Ching ^a,b   Lin, Jia Wei ^b   Cheng, Heien An ^c   Chiu, Wen Ta ^b   Wang, Yuan Hung ^b   Wang, Jhi Joung ^a   Hsing, Chung Hsi ^a   Chen, Ruei Ming ^b,d,e  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c YUAN'S GENERAL HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Bcl 2; HIF 1 ; Hypoxia; miR 210; Neural apoptosis

Indexed keywords

BETA ACTIN; CHAPERONIN 60; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MICRORNA 210; OXYGEN; PROTEIN BCL 2; PROTEIN BCL XL;

3' UNTRANSLATED REGION; ANIMAL CELL; APOPTOSIS; ARTICLE; BIOINFORMATICS; CELL HYPOXIA; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE SILENCING; IN VITRO STUDY; MOLECULAR PATHOLOGY; MOUSE; NEURAL APOPTOSIS; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; PROTEIN SYNTHESIS;

3' UNTRANSLATED REGIONS; ANIMALS; APOPTOSIS; BINDING SITES; CELL HYPOXIA; CELL LINE, TUMOR; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GLUCOSE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INDAZOLES; MICE; MICRORNAS; NEUROBLASTOMA; NEURONS; OXYGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA INTERFERENCE; RNA, MESSENGER; TIME FACTORS; TRANSFECTION;

EID: 84878845628     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-012-0965-5     Document Type: Article

References (40)

1. Borden EC, Kluger H, Crowley J (2008) Apoptosis: a clinical perspective. Nat Rev Drug Discov 7:959
2. Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, Sheldon H, Harris AL, Gleadle JM, Ragoussis J (2008) hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 14:1340-1348
3. Chan SY, Loscalzo J (2010) MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle 9:1072-1083
4. Chan DA, Krieg AJ, Turcotte S, Giaccia AJ (2007) HIF gene expression in cancer therapy. Methods Enzymol 435:323-345
5. Chang HC, Chen TL, Cheh RM (2009) Cytoskeleton interruption in human hepatoma HepG2 cells induced by ketamine occurs possibly through suppression of calcium mobilization and mitochondrial function. Drug Metab Dispos 37:24-31
6. Chang HC, Chen TG, Tai YT, Chen TL, Chiu WT, Chen RM (2011) Resveratrol attenuates oxidized LDL-evoked Lox-1 signaling and consequently protects against apoptotic insults to cerebrovascular endothelial cells. J Cereb Blood Flow Metab 31:842-854
7. Chen RM, Chen TL, Chiu WT, Chang CC (2005) Molecular mechanism of nitric oxide-induced osteoblast apoptosis. J Orthop Res 23:462-468
8. L gene expression. J Bone Min Res 25:2193-2204
9. Cherng YG, Chang HC, Lin YL, Kuo ML, Chiu WT, Chen RM (2008) Apoptotic insults to human chondrocytes induced by nitric oxide are involved in sequential events, including cytoskeletal remodeling, phosphorylation of mitogen-activated protein kinase kinase kinase-1, and Bax-mitochondria-mediated caspase activation. J Orthop Res 26:1018-1026
10. Chesnut RM, Marshall LF, Klauber MR (1993) The role of secondary brain injury in determining outcome from severe head injury. J Trauma 34:216-322
11. Dirnagl U, Becker K, Meisel A (2009) Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol 8:398-412
12. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G, Capogrossi MC, Martelli F (2008) MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 283:15878-15883
13. Fatemi A, Wilson MA, Johnston MV (2009) Hypoxic-ischemic encephalopathy in the term infant. Clin Perinatol 36:835-838
14. Gerstner ER, Duda DG, di Tomaso E, Ryg PA, Loeffler JS, Sorensen AG, Ivy P, Jain RK, Batchelor TT (2009) VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer. Nat Rev Clin Oncol 6:229-236
15. Huang X, Le QT, Giaccia AJ (2010) MiR-210-micromanager of the hypoxia pathway. Trends Mol Med 16:230-237
16. Ivan M, Harris AL, Martelli F, Kulshreshtha R (2008) Hypoxia response and microRNAs: no longer two separate worlds. J Cell Mol Med 12:1426-1431
17. Jana A, Hogan EL, Pahan K (2009) Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death. J Neurol Sci 278:5-15
18. Jovanovic M, Hengartner MO (2006) miRNAs and apoptosis: RNAs to die for. Oncogene 25:6176-6187
19. Kaur B, Khwaja FW, Severson EA, Matheny SL, Brat DJ, Van Meir EG (2005) Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol 7:134-153
20. Kim HW, Haider HK, Jiang S, Ashraf M (2009) Ischemic preconditioning augments survival of stem cells via MIR-210 expression by targeting caspase-8 associated protein 2. J Biol Chem 284:33161-33168
21. Kulshreshtha R, Ferracin M, Wojcik S, Garzon R, Alder H, Agosto-Perez FJ, Davuluri R, Liu CG, Croce CM, Negrini M, Calin GA, Ivan M (2007) A microRNA signature of hypoxia. Mol Cell Biol 27:1859-1867
22. Lee ST, Wu TT, Yu PY, Chen RM (2009) Apoptotic insults to human HepG2 cells induced by S-(+)-ketamine occurs through activation of a Bax-mitochondria-caspase protease pathway. Br J Anaesth 102:80-89
23. Lee CJ, Tai YT, Lin YL, Chen RM (2010) Molecular mechanisms of propofol-involved suppression of nitric oxide biosynthesis and inducible nitric oxide synthase gene expression in lipopolysaccharide-stimulated macrophage-like Raw 264.7 cells. Shock 33:93-100
24. Lin YL, Chang HC, Chen TL, Chang JH, Chiu WT, Chen RM (2010) Resveratrol protects against oxidized LDL-induced breakage of the blood-brain barrier by lessening disruption of tight junctions and apoptotic insults to mouse cerebrovascular endothelial cells. J Nutr 140:2187-2192
25. Lingsma HF, Roozenbeek B, Steyerberg EW, Murray GD, Maas AI (2010) Early prognosis in traumatic brain injury: from prophecies to predictions. Lancet Neurol 9:543-554
26. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X (2009) Bid, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481-490
27. Mathew LK, Simon MC (2009) mir-210: a sensor for hypoxic stress during tumorigenesis. Mol Cell 35:737-738
28. Mazzeo AT, Bullock R (2007) Monitoring brain tissue oximetry: will it change management of critically ill neurologic patients? J Neurol Sci 261:1-9
29. Merino D, Bouillet P (2009) The Bcl-2 family in autoimmune and degenerative disorders. Apoptosis 14:570-583
30. Negrini M, Nicoloso MS, Calin GA (2009) MicroRNAs and cancer-new paradigms in molecular oncology. Curr Opin Cell Biol 21:470-479
31. Pang JC, Kwok WK, Chen Z, Ng HK (2009) Oncogenic role of microRNAs in brain tumors. Acta Neuropathol 117:599-611
32. Pirzadeh A, Mammen A, Kubin J, Reade E, Liu H, Mendoza A, Greeley WJ, Wilson DF, Pastuszko A (2011) Early regional response of apoptotic activity in newborn piglet brain following hypoxia and ischemia. Neurochem Res 36:83-92
33. Semenza GL (2000) Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1. J Clin Invest 106:809-812
34. Tai YT, Cherng YG, Chang CC, Hwang YP, Chen JT, Chen RM (2007) Pretreatment with low nitric oxide protects osteoblasts from high nitric oxide-induced apoptotic insults through regulation of c-Jun N-terminal kinase/c-Jun-mediated Bcl-2 gene expression and protein translocation. J Orthop Res 25:625-635
35. Vandenabeele P, Galluzzi L, Berghe TV, Kroemer G (2010) Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11:700-714
36. Walls KC, Ghosh AP, Ballestas ME, Klocke BJ, Roth KA (2009) bcl-2/Adenovirus E1B 19-kd interacting protein 3 (BNIP3) regulates hypoxia-induced neural precursor cell death. J Neuropathol Exp Neurol 68:1326-1338
37. Wang H, Yao Y, Jiang X, Xiong Y, Mu D (2006) Expression of Nogo-A and NgR in the developing rat brain after hypoxia-ischemia. Brain Res 1114:212-220
38. Wu GJ, Chen TL, Ueng YF, Chen RM (2008) Ketamine inhibits tumor necrosis factor-α and interleukin-6 gene expressions in lipopolysaccharide- stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation. Toxicol Appl Pharmacol 228:105-113
39. Yin KJ, Deng Z, Hamblin M, Xiang Y, Huang H, Zhang J, Jiang X, Wang Y, Chen YE (2010) Peroxisome proliferator-activated receptor delta regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury. J Neurosci 30:6398-6408
40. Zhang Z, Sun H, Dai H, Walsh RM, Imakura M, Schelter J, Burchard J, Dai X, Chang AN, Diaz RL, Marszalek JR, Bartz SR, Carleton M, Cleary MA, Linsley PS, Grandori C (2009) MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle 8:2756-2768